Atlas Trials

Study on Paclitaxel Plus Topotecan in Comparison With Topotecan Plus Cisplatin in Recurrent or Persistent Cervical Carcinoma

Clinical trial NCT01405235 · UNKNOWN

Trial details

NCT number
NCT01405235
Sponsor
Institut fuer Frauengesundheit
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Recurrent, Persistent or Metastasized Cervical Cancer
Start date
2006-09-01
Primary completion
2012-06-01
Enrollment
312

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.